Our rich industry expertise in this domain has enabled us to offer Erlotinib Tablets IP. These tablets are highly effective in the subset of patients carrying EGFR mutations. Highly demanded in market for its purity and safe to use nature, these Erlotinib Tablets IP block proteins on cancer cells that encourage the cancer to grow. Further, these tablets are tested on varied parameters in order to ensure its superior quality.